文献速递外周动脉疾病

握力评估在慢性肢体威胁性缺血患者死亡风险预测中的作用

Utility of Hand Grip Strength in Predicting Mortality Risk in Chronic Limb-Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2026-07-03

结果显示握力定义的肌少症与2年死亡独立相关(HR 6.4;95%CI 2.4,17.2;P<0.001),提示握力可作为CLTI风险分层与共同决策的辅助工具。

要点

  • 握力定义的肌少症在CLTI患者中占26%,与2年死亡风险显著升高独立相关。
  • 肌少症患者年龄更大,且WIfI临床分期、衰弱与CCI评分更差。
  • 握力测量简便,可作为CLTI风险分层和共同决策的辅助指标。

核心结论

  • 握力定义的肌少症与CLTI患者更差的2年生存率强相关。
  • 握力可能作为CLTI风险分层和共同决策的有用辅助手段。

研究设计与样本

  • 单中心前瞻性队列研究(NCT04027244),纳入2019年5月至2021年5月因CLTI接受手术的患者。
  • 使用Jamar+数字握力计测量双侧坐位5次握力,取最大值;女性<16 kg、男性<27 kg定义为肌少症。
  • 采用Cox回归分析肌少症与2年死亡率的关联,多变量模型校正年龄、性别、衰弱和Charlson合并症指数(CCI)。

主要发现

  • 肌少症患者平均年龄大11.5岁(P<0.001)。
  • 肌少症与更差的WIfI临床分期(P=0.011)、衰弱(P=0.001)及更高CCI评分(P=0.012)相关。
  • 2年时25例(26%)死亡,其中17例(68%)有肌少症,8例(32%)无肌少症。
  • 肌少症与更差的2年死亡率独立相关(HR 6.4;95%CI 2.4,17.2;P<0.001)。

关键数值与推荐

  • 肌少症定义:最大握力女性<16 kg、男性<27 kg。
  • 握力测量:Jamar+数字握力计,双侧坐位各5次重复。

临床怎么用

  • 对CLTI患者可行简便的握力测量以识别肌少症高风险人群。
  • 握力结果可辅助风险分层,并用于与患者及家属的共同决策沟通。

局限性

  • 原文摘要未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic limb-threatening ischemia (CLTI) is associated with increased mortality, reported as high as 50% at 5 years. Sarcopenia, defined as low skeletal muscle strength, quantity, and quality, is associated with adverse outcomes. This study investigated the association of sarcopenia using hand grip strength with 2-year mortality in people with CLTI. METHODS: This single-center prospective cohort study (NCT04027244) included patients undergoing procedures for CLTI between May 2019 and May 2021 (minimum age: ≥65 initially; ≥50 from November 2019). Hand grip strength was measured using the Jamar+ digital hand dynamometer with 5 seated repetitions bilaterally. Sarcopenia was defined as maximum grip strength of <16 kg in women and <27 kg in men. The association of sarcopenia with 2-year mortality was analyzed using Cox regression and reported as hazard ratios (HRs) with 95% confidence intervals (CIs). The multivariable model adjusted for age, sex, frailty and Charlson comorbidity index (CCI). RESULTS: Ninety-seven participants were included. Twenty-five (26%) had sarcopenia on hand grip strength. Those with sarcopenia were a mean 11.5 years older (P < 0.001). Sarcopenia was also associated with worse Wound, Ischemia, foot Infection clinical stage (P = 0.011), frailty (P = 0.001), and greater CCI score (P = 0.012). At 2-years, 25 people (26%) had died: 17 of whom had sarcopenia (68%) compared to 8 without (32%). Sarcopenia was independently associated with worse 2-year mortality (HR 6.4; 95% CI 2.4, 17.2; P < 0.001). CONCLUSION: Hand grip strength was strongly associated with worse 2-year survival in people with CLTI. Grip strength may be a useful adjunct to risk stratification and aid shared decision-making in CLTI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Goves KG, Essop-Adam A, Black I, et al. Utility of Hand Grip Strength in Predicting Mortality Risk in Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2026. PMID: 42398809. doi:10.1016/j.avsg.2026.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。